Discrepancy in guidelines for the prevention of thrombo-embolism in patients with prosthetic heart valves
| Autor: | Alexandros Stefanidis, Evaggelos G. Papasteriadis, Dimitrios Skafidas |
|---|---|
| Rok vydání: | 2007 |
| Předmět: |
medicine.medical_specialty
Thrombo embolism business.industry valvular heart disease Atrial fibrillation macromolecular substances medicine.disease Internal medicine cardiovascular system Cardiology medicine In patient cardiovascular diseases Cardiology and Cardiovascular Medicine business Oral anticoagulation Prosthetic heart |
| Zdroj: | European Heart Journal. 28:2552-2553 |
| ISSN: | 1522-9645 0195-668X |
| Popis: | We have read with interest and became aware of diverse therapeutic approaches in several recently published guidelines, referring to patients with prosthetic heart valves and atrial fibrillation.1–3 In the latest European guidelines on the management of valvular heart disease,1 lifelong oral anticoagulation is recommended for all patients with mechanical valves and for those patients with bioprostheses who have additional indications for anticoagulation such as atrial fibrillation, … |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|